Use Biogen to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Biogen will likely underperform.
Steven Holtzman Executive Vice President - Corporate Development
Susan Alexander Executive Vice President General Counsel, Corporate Secretary
Biogen Price and Market Media
The median price of Biogen for the period between Tue, May 21, 2013 and Thu, Jun 20, 2013 is 223.03 with a coefficient of variation of 5.38. The daily time series for the period is distributed with a sample standard deviation of 12.01, arithmetic mean of 223.41, and mean deviation of 10.17. The Stock received substential amount of media coverage during this period.
Biogen Idec Inc [BIIB] is traded on NASDAQ in USA. It is located in Weston, MA and employs 5,950 people. The company currently falls under 'Large-Cap' category with current market capitalization of 50.32 B. Biogen Idec Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 237.37 M outstanding shares of which 2 M shares are currently shorted by private and institutional investors with about 2.2 trading days to cover.
Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-1.39% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
